Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathways in cancer | R-HSA-9824443 | map05200 | propranolol | 4946 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | propranolol | 4946 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | propranolol | 4946 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | propranolol | 4946 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | propranolol | 4946 | drug-path |
| Asthma | R-HSA-444620 | map05310 | propranolol | 4946 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | propranolol | 4946 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | propranolol | 4946 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | propranolol | 4946 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | bretylium tosilate | 6100 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | bretylium tosilate | 6100 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | bretylium tosilate | 6100 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | bretylium tosilate | 6100 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | bretylium tosilate | 6100 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | bretylium tosilate | 6100 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | bretylium tosilate | 6100 | drug-path |
| Asthma | R-HSA-444620 | map05310 | bretylium tosilate | 6100 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | bretylium tosilate | 6100 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | bretylium tosilate | 6100 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | bretylium tosilate | 6100 | drug-path |